Description

Eterna Peptides presents premium-grade TB500 (10mg) lyophilized powder, an advanced synthetic peptide representing the fully functional, short-chain acetylated fragment of the endogenous protein Thymosin Beta-4 ($T\beta\text{-}4$). Composed of a precise 43-amino-acid sequence (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser), TB500 retains the full biological potency of the complete parent molecule while exhibiting vastly superior systemic dispersion kinetics due to its lower molecular mass. Extensively evaluated within regenerative medicine, orthopedics, and wound healing sciences, this precise 10mg single-vial format serves as a premier investigative tool for tracking actin sequestration, accelerated endothelial cell migration, and myofibrillar structural recovery loops.

### Mechanism of Action
TB500 operates via direct intracellular interaction with structural cytoskeletal components to drive rapid systemic remodeling cascades:
* **G-Actin Monomer Sequestration:** At the core of its cellular mechanics, TB500 acts as the principal G-actin sequestering peptide in eukaryotic cells. By binding directly to globular actin ($G\text{-actin}$) monomers in a 1:1 ratio, it inhibits premature polymerisation, maintaining a dynamic cytosolic pool of building blocks required for rapid microfilament restructuring.
* **Upregulation of Cell Migration & Wound Healing:** When cellular matrices undergo simulated trauma, the rich G-actin pool allows for instantaneous cytoskeletal rearrangement. This drives the high-velocity migration of keratinocytes, fibroblasts, and endothelial cells directly into injured areas, accelerating epithelialization and tissue closure profiles.
* **Angiogenesis via Matrix Metalloproteinases:** TB500 stimulates a localized upregulation of Matrix Metalloproteinases ($MMPs$). This enzymatic activity dissolves localized basement membranes, allowing newly migrated endothelial cells to organize into stable, functioning capillary tubes (angiogenesis), drastically improving target tissue perfusion.
* **Downregulation of Pro-Inflammatory Cascades:** In tissue distress screening, TB500 suppresses chronic inflammatory pathways by downregulating toxic free radicals and pro-inflammatory cytokines like Interleukin-8 ($IL\text{-}8$). This reduction minimizes fibrotic scar tissue deposition, promoting true structural elasticity rather than unorganized collagen scarring.

### Research Applications
In preclinical and in vitro laboratory models, TB500 10mg vials are actively utilized to investigate:
* High-velocity myofibrillar cell migration, tendon/ligament fiber remodeling, and joint capsule recovery kinetics.
* Endothelial cell differentiation, capillary branching dynamics, and microvascular angiogenesis pathways.
* Intracellular G-actin transcription alterations, cell motility thermodynamics, and cytoskeletal stability assays.
* Attenuation of localized inflammatory stress, protection of cardiac tissue matrices, and fibrotic scar reduction parameters.

Our TB500 vials undergo strict laboratory stabilization, high-grade purification, and uniform vacuum-drying guidelines to ensure absolute peptide chain integrity, rapid reconstitution kinetics, and dependable experimental reproducibility.

—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*